1 min read
Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...
As you look to transition your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
We provide impactful solutions on both a full-service or functional service basis, including strategic regulatory guidance, clinical program design, and IND/CTA support through to successful regulatory approval.
Veristat team member Philip Ho , Business Development Director, Asia Pacific, will be at the venue— ready to listen to your needs and share Veristat’s expertise
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.

Website: Bio Asia Taiwan
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...
1 min read
Aug 12, 2026 Veristat Blog
AI is changing clinical development, but speed alone isn't enough. In a regulated industry, every output still has to...